Switch to
More onapp

Neuland Laboratories Ltd

NEULANDLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,948 cr, stock is ranked 793
Moderate RiskStock is 3.00x as volatile as Nifty
1,518.45110.30 (+7.83%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,948 cr, stock is ranked 793
Moderate RiskStock is 3.00x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
30.53
PB RatioPB Ratio
2.32
Dividend YieldDiv. Yield
0.33%
Sector PESector PE
35.81
Sector PBSector PB
4.37
Sector Div YldSctr Div Yld
0.90%

Forecast & RatingsDetailed Forecast 

67%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides custom manufacturing solutions (CMS) to develop and manufacture pharmaceutical ingredients and intermediates.

Investor PresentationView older 

May 10, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022670.32766.60953.01953.1616.4416.2180.6363.82
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Closure of trading window 
Announced OnSep 28, 2022

Neuland Laboratories Limited has informed the Exchange about Closure of trading window | Download

Neuland Laboratories Limited has informed the Exchange about Closure of trading window | Download

Spurt in Volume 
Announced OnSep 26, 2022

NEULANDLAB : Significant increase in volume has been observed in Neuland Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. | Download

NEULANDLAB : Significant increase in volume has been observed in Neuland Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. | Download

Cash Dividend 
Ex. DateJul 14, 2022

Final • Div/Share: ₹ 5

See all events